CSL Seqirus, a unit of the Australian biopharma CSL, is touting a surplus of its influenza vaccines in the U.S. ahead of the ...
Bookended by its first commercial-scale manufacturing of the radioisotope actinium-225 in January and an expected ...
Following news of a planned CEO departure for the United States’ top drug industry lobbying group, the Pharmaceutical ...
In Milan this week, Novo and Eli Lilly took the stage at the European Association for the Study of Diabetes 2026 meeting with ...
Alnylam Pharmaceuticals has teamed up with Pete Shaw, making the retired professional football player the star of its “Play ...
In addition, medical countermeasures and animal health products also qualify for 0% import duties. Drugs belonging to those ...
In addition to the 86 target medicines, the OMB also asked for information on two additional antibiotics, amoxicillin and ciprofloxacin, citing potential supply chain vulnerabilities. (iStock/Getty ...
Ronald Reagan was in the White House, Michael Jackson’s “Thriller” was pumping through Walkmans everywhere, and biotech was ...
INS is Gazyva’s second immune-mediated indication, following an approval last October in adult lupus nephritis, a potentially ...
BioNTech is set to shutter multiple sites in Germany, impacting about 1,800 jobs, after efforts to find buyers fell through.
Eli Lilly’s portfolio of weight loss and diabetes medications have become a dominant force in the market—but access to the ...
Although a clinical setback last year continues to loom in the background, AbbVie’s $8.7 billion bet on Cerevel Therapeutics ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results